Navigation Links
Metabolix Executives to Present at Leading Industry Conferences

CAMBRIDGE, Mass., June 10, 2013 /PRNewswire/ -- Metabolix, Inc. (NASDAQ: MBLX), an innovation-driven bioscience company focused on delivering sustainable solutions for plastics, chemicals and energy, today announced that its executives will be presenting at two leading industry conferences in June. Metabolix President and Chief Executive Officer Richard P. Eno will discuss trends in the biopolymers industry at Smithers Rapra's Biopolymers Symposium 2013 on June 11, and he will moderate a panel at the Biotechnology Industry Organization's (BIO) 10th Annual World Congress on Industrial Biotechnology on June 19. In addition, Max Senechal, Metabolix's vice president of biobased chemicals, will discuss commercialization strategies for renewable chemicals at BIO World Congress on June 17.


At the Biopolymers Symposium, Mr. Eno will participate in a panel discussion with executives from NatureWorks and Virent. The session will focus on the future of biopolymers, and Mr. Eno will address Metabolix's experience working with customers to achieve commercial success.

At the BIO World Congress on Industrial Biotechnology, Mr. Senechal will participate in the "Renewable Chemicals through Strain Engineering and Process Optimization" panel discussion. Executives and researchers from Green Biologics, zuChem, PRAJ-Matrix and the University of Illinois will also be part of the session. Separately, Mr. Eno will be moderating the "Biomanufacturing at Commercial Scale" panel discussion on commercializing renewable chemicals with executives from Genomatica, Myriant, Clariant and Ajinomoto. Smithers Rapra's Biopolymers Symposium 2013What:"The Future of Biopolymers" panel discussionWho:Richard Eno, president and CEO, MetabolixWhen:Tuesday, June 11, 2013 from 8:40-9:40 a.m. Where: The Field Museum1400 S Lake Shore DriveChicago, IL, 60605 BIO's 10th Annual World Congress on Industrial BiotechnologyWhat:"Renewable Chemicals through Strain Engineering and Process Optimization" and "Biomanufacturing at Commercial Scale" panel discussionsWho:Max Senechal, vice president of biobased chemicals, and Richard Eno, president and CEO, MetabolixWhen:Monday, June 17 from 8:30-10 a.m. (Senechal) and Wednesday, June 19 from 8-10 a.m. (Eno)Where: Palais des congres de Montreal159 Saint-Antoine West, 9th floorMontreal (Quebec) H2Z 1H2, CanadaAbout Metabolix Metabolix, Inc. is an innovation-driven bioscience company delivering sustainable solutions to the plastics, chemicals and energy industries. Metabolix is developing and commercializing a family of high-performance biopolymers targeted to the markets for film and bag applications, performance additives and functional biodegradation. Metabolix's biobased chemicals platform utilizes its novel "FAST" recovery process to enable the production of cost-effective, alternative replacements for petroleum-based industrial chemicals. Metabolix is also developing a platform for co-producing plastics, chemicals and energy from crops. Metabolix has established an industry-leading intellectual property portfolio that, together with its knowledge of advanced industrial practice, provides a foundation for industry collaborations.

For more information, please visit (MBLX-G)


SOURCE Metabolix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. GDS International Combines Top Healthcare Executives in the United States for its 10th Anniversary NG Healthcare Summit in May
2. GDS International Confirms the Attendance of Top Executives to its Eleventh North American Healthcare Summit in December
3. Lucas Bagnell Varga LLC Secures $17.4 Million Award For Former Applied Biosystems Executives
4. OpenClinica to Exhibit at SCOPE (Summit for Clinical Ops Executives)
5. Aratana Therapeutics Adds Product Manufacturing Expertise with the Appointment of Two Senior Executives
6. Industry Executives to Explore the Future of Life Sciences Research Powered By Big Data Analytics
7. Executives from Johnson & Johnson, GlaxoSmithKline and California State Board of Pharmacy discuss pharmaceutical packaging challenges at Pharmapack North America 2013
8. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
9. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
10. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
11. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
Post Your Comments:
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... While ... machines such as the Cary 5000 and the 6000i models are higher end machines ... is the height of the spectrophotometer’s light beam from the bottom of the cuvette ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in clinical ... Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits ... tips, tools, and strategies for clinical researchers. , “The landscape of how patients ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... June 23, 2016 A person commits a crime, ... scene to track the criminal down. An outbreak ... and Drug Administration (FDA) uses DNA evidence to track down ... Sound far-fetched? It,s not. The FDA has increasingly used ... investigations of foodborne illnesses. Put as simply as possible, whole ...
Breaking Biology Technology:
(Date:6/2/2016)... , June 2, 2016   The Weather Company , ... Watson Ads, an industry-first capability in which consumers will be ... able to ask questions via voice or text and receive ... Marketers have long sought an advertising ... that can be personal, relevant and valuable; and can scale ...
(Date:5/16/2016)... May 16, 2016   EyeLock LLC , a ... the opening of an IoT Center of Excellence in ... expand the development of embedded iris biometric applications. ... of convenience and security with unmatched biometric accuracy, making ... aside from DNA. EyeLock,s platform uses video technology to ...
(Date:4/28/2016)... Sweden , April 28, 2016 First ... M (139.9), up 966% compared with the first quarter of 2015 ... profit totaled SEK 589.1 M (loss: 18.8) and the operating margin ... 7.12 (loss: 0.32) Cash flow from operations was SEK ... The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
Breaking Biology News(10 mins):